Proleukin
- Product NDC
- 76310-022
- 11-digit product format
- 763100022
- Labeler code
- 76310
- Product ID
- 76310-022_68da1212-9acf-426a-b3f1-2d20113d7d4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- aldesleukin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Clinigen Limited
- Application
- BLA103293
- Marketing category
- BLA
- Marketing start
- 1992-05-05
- Marketing end
- 0000-00-00
- Substance
- ALDESLEUKIN
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Increased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interleukin-2 [CS], Lymphocyte Growth Factor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 76310-022 | PROLEUKIN (ALDESLEUKIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CLINIGEN LIMITED] | 7 | Legacy NDC | 20240622_deead498-9f19-48cf-87c7-6caf2263f2ab.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 76310-022-01 | 76310002201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (76310-022-01) > 1 mL in 1 VIAL, SINGLE-DOSE | 2019-12-31 | 0000-00-00 | No | No | Current |